Roger New
Voorzitter bij Proxima Concepts Ltd.
Profiel
Roger New was the founder of Botanix Pharmaceuticals Ltd.
(founded in 1984) where he held the title of Non-Executive Chairman & Chief Scientific Officer from 2012 to 2014.
He was also the founder of Kancer Ltd.
(founded in 1980) where he served as a Co-Founding Director.
Currently, Dr. New is the Chairman & Chief Scientific Officer at Proxima Concepts Ltd.
since 2012.
He is also the Chief Scientist at Proxima Corp.
since 2000 and the Chief Scientific Officer at Diabetology Ltd.
In the past, Dr. New worked as a Director at Bone, Ltd.
and as a Principal at Provalis Plc.
Actieve functies van Roger New
| Bedrijven | Functie | Begin |
|---|---|---|
Diabetology Ltd.
 Diabetology Ltd. Miscellaneous Commercial ServicesCommercial Services Diabetology Ltd. offers biopharmaceutical research and development services. It develops Capsulin and novel Axcess oral form of insulin for diabetics that incorporates absorption enhancers with unmodified bioactive in a convenient encapsulated form. The company was founded by Roger New and Glen Travers in 2002 and is headquartered in St. Helier, Jersey. | Hoofd Techniek/Wetenschap/O&O | - |
Proxima Corp.
 Proxima Corp. Computer PeripheralsElectronic Technology Part of Ask ASA, Proxima Corp. is a company that makes multimedia projection products. The company is based in Wilsonville, OR. Proxima was acquired by Ask ASA on April 13, 1998 for $82.03 million. | Hoofd Techniek/Wetenschap/O&O | 01-01-2000 |
| Proxima Concepts Ltd. | Voorzitter | 27-03-2012 |
Eerdere bekende functies van Roger New
| Bedrijven | Functie | Einde |
|---|---|---|
| Bone, Ltd. | Directeur/Bestuurslid | 16-03-2011 |
Kancer Ltd.
 Kancer Ltd. Miscellaneous Commercial ServicesCommercial Services Kancer Ltd. engages in the provision of cancer treatments. Its projects include personalized medicine, targeted destruction of cancer cells, oral granulocyte colony stimulating factor , and oral interferon. The company was founded by Glen Travers and Roger New in 1980 and is headquartered in Saint Helier, the United Kingdom. | Oprichter | - |
| BOTANIX PHARMACEUTICALS LIMITED | Oprichter | - |
| Provalis Plc | Corporate Officer/Principal | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| BOTANIX PHARMACEUTICALS LIMITED | Health Technology |
| Bedrijven in privébezit | 6 |
|---|---|
Diabetology Ltd.
Diabetology Ltd. Miscellaneous Commercial ServicesCommercial Services Diabetology Ltd. offers biopharmaceutical research and development services. It develops Capsulin and novel Axcess oral form of insulin for diabetics that incorporates absorption enhancers with unmodified bioactive in a convenient encapsulated form. The company was founded by Roger New and Glen Travers in 2002 and is headquartered in St. Helier, Jersey. | Commercial Services |
| Provalis Plc | Health Technology |
Proxima Corp.
Proxima Corp. Computer PeripheralsElectronic Technology Part of Ask ASA, Proxima Corp. is a company that makes multimedia projection products. The company is based in Wilsonville, OR. Proxima was acquired by Ask ASA on April 13, 1998 for $82.03 million. | Electronic Technology |
| Bone, Ltd. | Health Technology |
| Proxima Concepts Ltd. | |
Kancer Ltd.
Kancer Ltd. Miscellaneous Commercial ServicesCommercial Services Kancer Ltd. engages in the provision of cancer treatments. Its projects include personalized medicine, targeted destruction of cancer cells, oral granulocyte colony stimulating factor , and oral interferon. The company was founded by Glen Travers and Roger New in 1980 and is headquartered in Saint Helier, the United Kingdom. | Commercial Services |
